Evidence map›Paper›PMID 41291418›Full record

ArticleBMC microbiology2025

Valorisation of acid whey permeate for high-purity nisin Z production using artisanal Lactococcus lactis isolates.

Humna Liaqat, Diana Paveljšek, Jernej Oberčkal, Bojana Bogovič Matijašić

Abstract read
In one paragraph

Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Humna LiaqatDepartment of Animal Science, Biotechnical Faculty, University of Ljubljana, Groblje 3, Domžale, 1230, Slovenia.
Diana PaveljšekDepartment of Animal Science, Biotechnical Faculty, University of Ljubljana, Groblje 3, Domžale, 1230, Slovenia.
Jernej OberčkalDepartment of Animal Science, Biotechnical Faculty, University of Ljubljana, Groblje 3, Domžale, 1230, Slovenia.
Bojana Bogovič MatijašićDepartment of Animal Science, Biotechnical Faculty, University of Ljubljana, Groblje 3, Domžale, 1230, Slovenia. Bojana.BogovicMatijasic@bf.uni-lj.si.

Funding

European Commission LIFE16 ENV/SI/000335The Slovenian Research and Innovation Agency Research program P4-0097The Slovenian Research and Innovation Agency Young Researchers' Program, grant number 802-6/2021
6 · The paper itself

Abstract

The growing demand for sustainable bioprocessing has positioned whey, a side stream of the dairy industry, as a valuable substrate for producing high-value compounds. This study investigated the production and purification of nisin, a potent lantibiotic, using permeate (10 kDa cut-off) of ultrafiltered acid whey (PUFAW) devoid of lactoferrin as growth medium. Three strains of Lactococcus lactis subsp. lactis, including two artisanal isolates (IM 143 and IM 145) and a reference strain (IM 407), were evaluated for nisin production in PUFAW supplemented with yeast extract (YE) and mineral salts. Strain IM 145 showed superior growth and antimicrobial activity in PUFAW with YE (30 g/L) and produced up to 51,200 BA/mL of nisin. The bacteriocin was purified by ammonium sulphate precipitation followed by preparative RP-HPLC, yielding a product with 79.2% chromatographic purity. Tricine-SDS-PAGE and mass spectrometry confirmed the identity of the purified compound as nisin Z. This study presents a cost-effective, circular economy approach for the production of high-purity nisin from dairy side streams, with potential applications in food preservation and biomedicine.

Indexed as

Anti-Bacterial AgentsLactococcus lactisNisinWheyCulture MediaAnti-Bacterial AgentsCulture MediaNisinnisin ZAcid whey permeateBacteriocinCircular economyLactococcus lactisNisin ZRP-HPLC

Identifiers

PMID41291418
PMCPMC12777345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.